Related Experiment Videos
In vitro effect of a mucolytic thiol agent on the activity of polymorphonuclear leucocyte elastase and
Abstract:
We have studied the effects of the mucolytic thiol agent mercapto-ethanesulphonate (mesna) on the activity of both polymorphonuclear leucocyte (PMN) elastase and antileucoprotease in vitro. In all tests a specific synthetic substrate was used to measure elastase activity, which was then related to enzyme activity in the absence of mesna. The relative elastase activity decreased to 67.5% of control values after the enzyme had been incubated in a 120 mmol/l mesna solution. In the sol phase of purulent sputum, elastase activity decreased to 45% after the sol phase had been incubated in a 600 mmol/l mesna solution. The inability to reverse the inhibition of mesna by increasing the substrate concentration indicated that mesna acts as a non-competitive inhibitor of PMN elastase. Incubation of elastase with antileucoprotease reduced the relative elastase activity to 21%. When antileucoprotease was preincubated in a 60 mmol/l mesna solution under identical assay conditions, a relative elastase activity of 39% was observed. Inhibition experiments with mesna treated antileucoprotease, in which sulphydryl groups were blocked with iodoacetamide, strongly suggested that the dissociation constant (Ki) of the fraction of antileucoprotease that retains activity after the incubation with mesna was not changed. Elastase inhibitory activity in mucoid sol phase, which can be ascribed mainly to antileucoprotease, decreased to 53% after incubation with mesna at a concentration of 960 mmol/l. Incubation of PMN elastase/antileucoprotease complex with mesna did not result in any release of active PMN elastase from the antileucoprotease. It is concluded that mesna and other thiol compounds, when locally administered, may influence the proteinase-antiproteinase balance in the airways by their effect on both PMN elastase and antileucoprotease.
Insights
Mercapto-ethanesulphonate (mesna), a mucolytic thiol agent, inhibits polymorphonuclear leucocyte (PMN) elastase and affects antileucoprotease activity. These actions may alter the proteinase-antiproteinase balance in airways when mesna is administered locally.
Area of Science:
- Biochemistry
- Pharmacology
- Respiratory Medicine
Background:
- Polymorphonuclear leucocyte (PMN) elastase is implicated in airway inflammation and tissue damage.
- Antileucoprotease is a key inhibitor of PMN elastase, maintaining proteinase-antiproteinase balance.
- Mucolytic agents like mercapto-ethanesulphonate (mesna) are used to treat respiratory conditions.
Purpose of the Study:
- To investigate the in vitro effects of mesna on PMN elastase activity.
- To determine mesna's impact on antileucoprotease function.
- To understand how mesna influences the proteinase-antiproteinase balance in airways.
Main Methods:
- Enzyme activity assays using specific synthetic substrates to measure elastase activity.
- Incubation of PMN elastase and antileucoprotease with varying concentrations of mesna.
- Inhibition studies with iodoacetamide to probe the mechanism of mesna's effect on antileucoprotease.
Main Results:
- Mesna non-competitively inhibited PMN elastase activity in a dose-dependent manner.
- Mesna reduced elastase inhibitory activity of antileucoprotease in a concentration-dependent manner.
- Mesna did not cause the release of active PMN elastase from its complex with antileucoprotease.
Conclusions:
- Mesna directly inhibits PMN elastase activity.
- Mesna modulates the inhibitory capacity of antileucoprotease.
- Local administration of mesna may influence the proteinase-antiproteinase balance in airways.